Download Files:
Enzaplatovir
$650 – $2,200
Products Details
Product Description
– Enzaplatovir (BTA-C585) is an orally bioavailable Inhibitor for respiratory syncytial virus (RSV) infection[1].
Web ID
– HY-109004
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C20H19N5O3
References
– [1]Eric A F Simões, et al. Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children. Infect Dis Ther. 2018 Mar;7(1):87-120.
CAS Number
– 1323077-89-9
Molecular Weight
– 377.40
Compound Purity
– 99.98
SMILES
– O=C(C1=CON=C1C)N2[C@](CN3C4=CC=C3)(C(C=C5)=CN=C5C)N(CC2)C4=O
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– DMSO : 200 mg/mL (ultrasonic)
Target
– RSV
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
